Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yohimbine for Type 2 Diabetes with Genetic Risk Variant
NCT01593215Phase 2Completed
- Start
- May 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of yohimbine in type 2 diabetes mellitus (T2DM). Started May 2012; status: completed.
02
Drugs
yohimbine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01593215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01593215.